Xiaoying Wei
Impact in
-
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA modifications and cancer 2
- DNA Repair Mechanisms 1
- Oncology 7
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 2
- Co-authors
- Weihua Zhang (1 shared paper)Aiguo Xu (1 shared paper)X. Hao (2 shared papers)Ruifang Niu (1 shared paper)Yu Shi (1 shared paper)Yiling Yang (1 shared paper)Qingsong Pang (7 shared papers)Zhiyong Yuan (3 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Frontiers in Bioengineering and Biotechnology (1 paper)HemaSphere (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Journal of Leukocyte Biology (1 paper)
- Partner nations
- ChinaUnited StatesNepal
In The Last Decade
Xiaoying Wei
22 papers receiving 358 citations
Peers
Comparison fields: 5 of 62
- Oncology 111
- Cancer Research 51
- Nutrition and Dietetics 37
- Biotechnology 18
- Ophthalmology 16
Countries citing papers authored by Xiaoying Wei
This map shows the geographic impact of Xiaoying Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoying Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoying Wei more than expected).
Fields of papers citing papers by Xiaoying Wei
This network shows the impact of papers produced by Xiaoying Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoying Wei. The network helps show where Xiaoying Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoying Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Up-regulation of Twist induces angiogenesis and correlates with metastasis in hepatocellular carcinoma. | 2007 | 96 |
| 2 | 2020 | 65 | |
| 3 | 2019 | 51 | |
| 4 | 2022 | 29 | |
| 5 | 2016 | 20 | |
| 6 | 2020 | 19 | |
| 7 | 2013 | 18 | |
| 8 | 2022 | 11 | |
| 9 | 2021 | 9 | |
| 10 | 2025 | 9 | |
| 11 | 2020 | 7 | |
| 12 | Reversing adriamycin resistance of human breast cancer cells by hyperthermia combined with Interferon alpha and Verapamil. | 2007 | 6 |
| 13 | 1987 | 5 | |
| 14 | 2022 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 2025 | 3 | |
| 17 | 2022 | 3 | |
| 18 | 2025 | 3 | |
| 19 | 2021 | 2 | |
| 20 | 2020 | 2 |
About Xiaoying Wei
Xiaoying Wei is a scholar working on Molecular Biology, Oncology, Surgery, Immunology and Pulmonary and Respiratory Medicine, having authored 23 papers that have together received 367 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Esophageal Cancer Research and Treatment (4 papers), Cancer, Lipids, and Metabolism (2 papers), CAR-T cell therapy research (2 papers), Immunotherapy and Immune Responses (2 papers), RNA modifications and cancer (2 papers), Cancer-related molecular mechanisms research (2 papers) and DNA Repair Mechanisms (1 paper). The work is most often cited by research in Oncology (111 citations), Cancer Research (51 citations), Nutrition and Dietetics (37 citations), Biotechnology (18 citations) and Ophthalmology (16 citations). Xiaoying Wei has collaborated with scholars based in China, United States and Nepal. Frequent co-authors include Weihua Zhang, Aiguo Xu, X. Hao, Ruifang Niu, Yu Shi, Yiling Yang, Qingsong Pang, Zhiyong Yuan, Jingjing Cheng and Xiaofeng Ding. Their work appears in journals such as Frontiers in Immunology, Frontiers in Bioengineering and Biotechnology, HemaSphere, Journal for ImmunoTherapy of Cancer and Journal of Leukocyte Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.